Resolvin D1 suppresses macrophage senescence and splenic fibrosis in aged mice
Prostaglandins, Leukotrienes and Essential Fatty Acids · 2024-03 · 202 · 102634
DOI: 10.1016/j.plefa.2024.102634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2024-03. Verfasst von Anouk G Groenen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Spleen, Macrophages, Docosahexaenoic Acids, Cellular Senescence. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Centre Groningen, National Institutes of Health, Rijksuniversiteit Groningen.
Abstract (Originalsprache)
Aging is associated with systemic, non-resolving inflammation and the accumulation of senescent cells. The resolution of inflammation (or inflammation-resolution) is in part mediated by the balance between specialized pro-resolving mediators (SPMs) and pro-inflammatory leukotrienes (LTs). Aged mice (i.e. 2 years of age) exhibit a significant decrease in the SPM:LT ratio in specific organs including the spleen, which suggests that this organ may exhibit heightened inflammation and may be particularly amenable to SPM therapy. Previous studies have shown that resolvin D1 (RvD1) is decreased in spleens of aged mice compared with young controls. Therefore, we asked whether treatment of RvD1 in aged mice would impact markers of cellular senescence in splenic macrophages, and downstream effects on splenic fibrosis, a hallmark of splenic aging. We found that in aged mice, both zymosan-elicited and splenic macrophages showed an increase in mRNA expression of inflammatory and eicosanoid biosynthesis genes and a dysregulation of genes involved in the cell cycle. Injections with RvD1 reversed these changes. Importantly, RvD1 also decreased splenic fibrosis, a hallmark of splenic aging. Our findings suggest that RvD1 treatment may limit several features of aging, including senescence and fibrosis in spleens from aged mice. Summary Aging is associated with systemic, low grade, non-resolving inflammation. The resolution of inflammation is in part mediated by the balance between specialized pro-resolving mediators (SPMs) and pro-inflammatory lipid mediators, like leukotrienes (LTs). A hallmark of aging is the accumulation of senescent cells that promote low grade inflammation by secreting pro-inflammatory cytokines and lipid mediators. Splenic macrophages contribute to systemic aging, and spleens of aged mice demonstrate decreased levels of the SPM called resolvin D1 (RvD1). Whether addition of RvD1 is protective in spleens of aged mice is unknown and is focus of this study. RvD1 treatment to aged mice led to decreased mRNA expression of markers of cellular senescence and inflammation in splenic macrophages compared with age-matched vehicle controls. Moreover, RvD1 decreased splenic fibrosis, which occurs due to persistent low-grade inflammation in aging. Promoting inflammation resolution with RvD1 thus limits macrophage senescence, pro-inflammatory signals and established splenic fibrosis in aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York, NY, USA.
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York, NY, USA. Electronic address: fredmag@amc.edu.
- Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: m.westerterp@umcg.nl.
Förderung
- University Medical Centre Groningen
- National Institutes of Health
- Rijksuniversiteit Groningen
- Netherlands Organisation for Scientific Research
- Stichting De Cock - Hadders
Zitieren
APA
Groenen, A. G., Lipscomb, M., Bossardi Ramos, R., Sadhu, S., Bazioti, V., Fredman, G., & Westerterp, M. (2024). Resolvin D1 suppresses macrophage senescence and splenic fibrosis in aged mice. Prostaglandins, Leukotrienes and Essential Fatty Acids, 202, 102634. https://doi.org/10.1016/j.plefa.2024.102634
Vancouver
Groenen AG, Lipscomb M, Bossardi Ramos R, Sadhu S, Bazioti V, Fredman G, et al. Resolvin D1 suppresses macrophage senescence and splenic fibrosis in aged mice. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2024;202:102634. doi:10.1016/j.plefa.2024.102634
BibTeX
@article{Groenen2024,
author = {Groenen, Anouk G and Lipscomb, Masharh and Bossardi Ramos, Ramon and Sadhu, Sudeshna and Bazioti, Venetia and Fredman, Gabrielle and Westerterp, Marit},
title = {Resolvin D1 suppresses macrophage senescence and splenic fibrosis in aged mice},
journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
year = {2024},
volume = {202},
pages = {102634},
doi = {10.1016/j.plefa.2024.102634}
}
EUVIMED